Pantoprazole Sodium
Product Images NDC 70934-475

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 70934-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 475 30 Master Bottle Label Approval Rev A 12 19)

Label (70934 475 30 Master Bottle Label Approval Rev A 12 19)
Pantoprazole Sodium Delayed-Release Tablets, USP 20 mg, carton label from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. Contains 30 tablets. The label includes storage instructions, dosage form, NDC (70934-475-30), and caution to keep out of reach of children.*
FDA Label Image

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)
Chemical structure of Pantoprazole Sodium showing its molecular framework including methoxy and difluoromethoxy groups, sodium ion, and 1.5 molecules of water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.